![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: NMT2 |
Gene summary for NMT2 |
![]() |
Gene information | Species | Human | Gene symbol | NMT2 | Gene ID | 9397 |
Gene name | N-myristoyltransferase 2 | |
Gene Alias | NMT2 | |
Cytomap | 10p13 | |
Gene Type | protein-coding | GO ID | GO:0006464 | UniProtAcc | B3KT39 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9397 | NMT2 | NAFLD1 | Human | Liver | NAFLD | 7.50e-08 | 7.26e-01 | -0.04 |
9397 | NMT2 | HCC1_Meng | Human | Liver | HCC | 8.08e-05 | -1.78e-01 | 0.0246 |
9397 | NMT2 | HCC2_Meng | Human | Liver | HCC | 1.47e-08 | -1.32e-01 | 0.0107 |
9397 | NMT2 | HCC1 | Human | Liver | HCC | 4.92e-22 | 4.41e+00 | 0.5336 |
9397 | NMT2 | HCC2 | Human | Liver | HCC | 1.25e-29 | 3.70e+00 | 0.5341 |
9397 | NMT2 | HCC5 | Human | Liver | HCC | 7.48e-19 | 2.84e+00 | 0.4932 |
9397 | NMT2 | Pt13.b | Human | Liver | HCC | 9.11e-04 | -1.66e-02 | 0.0251 |
9397 | NMT2 | Pt14.b | Human | Liver | HCC | 3.07e-02 | 1.74e-01 | 0.018 |
9397 | NMT2 | S014 | Human | Liver | HCC | 1.10e-02 | 2.50e-01 | 0.2254 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00160327 | Liver | NAFLD | viral process | 80/1882 | 415/18723 | 7.71e-09 | 1.07e-06 | 80 |
GO:00190587 | Liver | NAFLD | viral life cycle | 57/1882 | 317/18723 | 1.00e-05 | 3.18e-04 | 57 |
GO:00712145 | Liver | NAFLD | cellular response to abiotic stimulus | 56/1882 | 331/18723 | 7.01e-05 | 1.47e-03 | 56 |
GO:01040045 | Liver | NAFLD | cellular response to environmental stimulus | 56/1882 | 331/18723 | 7.01e-05 | 1.47e-03 | 56 |
GO:0043543 | Liver | NAFLD | protein acylation | 43/1882 | 243/18723 | 1.70e-04 | 3.07e-03 | 43 |
GO:00714783 | Liver | NAFLD | cellular response to radiation | 33/1882 | 186/18723 | 8.76e-04 | 1.07e-02 | 33 |
GO:001603222 | Liver | HCC | viral process | 286/7958 | 415/18723 | 4.41e-28 | 1.86e-25 | 286 |
GO:001905822 | Liver | HCC | viral life cycle | 209/7958 | 317/18723 | 2.05e-17 | 2.09e-15 | 209 |
GO:00435432 | Liver | HCC | protein acylation | 157/7958 | 243/18723 | 2.40e-12 | 1.12e-10 | 157 |
GO:00421571 | Liver | HCC | lipoprotein metabolic process | 86/7958 | 135/18723 | 5.21e-07 | 8.38e-06 | 86 |
GO:007121421 | Liver | HCC | cellular response to abiotic stimulus | 183/7958 | 331/18723 | 1.59e-06 | 2.26e-05 | 183 |
GO:010400421 | Liver | HCC | cellular response to environmental stimulus | 183/7958 | 331/18723 | 1.59e-06 | 2.26e-05 | 183 |
GO:00714782 | Liver | HCC | cellular response to radiation | 104/7958 | 186/18723 | 1.48e-04 | 1.19e-03 | 104 |
GO:00421581 | Liver | HCC | lipoprotein biosynthetic process | 58/7958 | 96/18723 | 2.99e-04 | 2.13e-03 | 58 |
GO:0044766 | Liver | HCC | multi-organism transport | 17/7958 | 21/18723 | 3.71e-04 | 2.56e-03 | 17 |
GO:1902579 | Liver | HCC | multi-organism localization | 17/7958 | 21/18723 | 3.71e-04 | 2.56e-03 | 17 |
GO:00064971 | Liver | HCC | protein lipidation | 55/7958 | 92/18723 | 6.12e-04 | 3.82e-03 | 55 |
GO:0046794 | Liver | HCC | transport of virus | 15/7958 | 19/18723 | 1.36e-03 | 7.28e-03 | 15 |
GO:00093146 | Liver | HCC | response to radiation | 223/7958 | 456/18723 | 3.08e-03 | 1.43e-02 | 223 |
GO:0075733 | Liver | HCC | intracellular transport of virus | 9/7958 | 11/18723 | 9.51e-03 | 3.60e-02 | 9 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
NMT2 | SNV | Missense_Mutation | c.1180G>T | p.Gly394Cys | p.G394C | O60551 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-CV-6937-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
NMT2 | SNV | Missense_Mutation | novel | c.802N>C | p.Glu268Gln | p.E268Q | O60551 | protein_coding | deleterious(0) | probably_damaging(0.944) | TCGA-CV-A6K2-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
NMT2 | SNV | Missense_Mutation | novel | c.211G>C | p.Asp71His | p.D71H | O60551 | protein_coding | deleterious(0.03) | probably_damaging(0.933) | TCGA-P3-A6T6-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cetuximab | PD |
NMT2 | SNV | Missense_Mutation | c.554N>G | p.Asp185Gly | p.D185G | O60551 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-BR-7707-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
NMT2 | SNV | Missense_Mutation | c.1124N>C | p.His375Pro | p.H375P | O60551 | protein_coding | deleterious(0) | probably_damaging(0.991) | TCGA-BR-8591-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
NMT2 | SNV | Missense_Mutation | c.1039N>T | p.Asp347Tyr | p.D347Y | O60551 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR | |
NMT2 | SNV | Missense_Mutation | c.667A>C | p.Lys223Gln | p.K223Q | O60551 | protein_coding | deleterious(0.02) | possibly_damaging(0.661) | TCGA-CD-5801-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD | |
NMT2 | SNV | Missense_Mutation | novel | c.1273N>G | p.Tyr425Asp | p.Y425D | O60551 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-VQ-A91D-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | PD |
NMT2 | insertion | In_Frame_Ins | novel | c.859_860insAAAGAATACTGGACT | p.Val287delinsGluArgIleLeuAspLeu | p.V287delinsERILDL | O60551 | protein_coding | TCGA-FY-A4B0-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Hormone Therapy | synthroid | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |